Comparison of Sealing Ability of MTA and Biodentine for Repairing of Furcal Perforation in Primary Molars
NCT ID: NCT05006755
Last Updated: 2021-08-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
42 participants
INTERVENTIONAL
2021-09-10
2022-09-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* furcal perforations may occur due to iatrogenic and non-iatrogenic causes.
* Despite the high successful outcomes in perforation repair with MTA, there are some issues which prevent the clinicians from using it for many cases such as its very long setting time and its difficult manipulation.
* Biodentin could be used as an alternative to MTA in reparative treatment procedures due to its ability to provide a hermetic seal and durable restoration and thus an optimal sealing is expected.
* The importance of the trial lies in testing the sealing ability of Biodentine using scanning electron microscope. Biodentine has short setting time and is easier in manipulation than MTA which are major needs when dealing with pediatric patients to be able to give best results in short time.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Furcal Perforation Repair in Primary Molars With MTA Versus Bioceramics (A Randomized Clinical Trial)
NCT04137861
3Mixtatin and MTA Vital Pulpotomy in Primary Molars
NCT06478940
Partial Versus Complete Pulpotomy Using Three Different Materials in Primary Molars: a Clinical Study
NCT05190783
Bioactive Materials in Pulp Therapy of Primary Teeth
NCT04795830
Evaluation for Healing of Iatrogenic Perforation After Repair With Different Materials
NCT06976411
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* MTA has high clinical efficacy, but there were some drawbacks which made it difficult for the clinicians to use it in many cases. The major ones being very long setting time and difficult manipulation.
* Biodentine has a good sealing ability, high compressive strengths, short setting time, biocompatibility, bioactivity and biomineralization properties that make it available to be used in endodontic repair procedures.
* 42 extracted primary molar teeth will be collected, sterilized and stored according to the Occupational Safety and Health Administration guidelines and regulations.
* A standard access cavity will be prepared in each tooth using a diamond bur and non-end cutting bur in high-speed handpiece with water spray. A 0.5 mm round bur will be used to standardize the size of furcal perforation, and the furcal involvement will be made on the center of the pulpal floor.
* After the furcal perforation, the blocks will randomly be divided into two groups
* Control group: MTA Group, Using amalgam applicator the material will be carried and sealed in the furcation site.
* Intervention group: Biodentin Group,The material will be scooped and applied on the perforation site.
* Outcome : sealing ability measurement method : scanning electron microscope unit of measurement : µm
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
the group of primary molar teeth that will be treated in furcal perforation with Mineral Trioxide Aggregate
Mineral Trioxide Aggregate
Mineral Trioxide Aggregate stimulates cementoblasts to produce matrix for cementum formation and is biocompatible with the periradicular tissues thus shows a superior sealing ability when used in perforation repair
experimental group
the group of primary molar teeth that will be treated in furcal perforation with Biodentine
Biodentine
Biodentine has a good sealing ability, high compressive strengths, short setting time, biocompatibility, bioactivity and biomineralization properties that make it available to be used in endodontic repair procedures
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mineral Trioxide Aggregate
Mineral Trioxide Aggregate stimulates cementoblasts to produce matrix for cementum formation and is biocompatible with the periradicular tissues thus shows a superior sealing ability when used in perforation repair
Biodentine
Biodentine has a good sealing ability, high compressive strengths, short setting time, biocompatibility, bioactivity and biomineralization properties that make it available to be used in endodontic repair procedures
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primary molars with intact furcation ( no caries, no perforation, no resorption )
* Physiologic root resorption not more than two-third of root length
Exclusion Criteria
* Primary molars with internal resorption
* Primary molars with extensive tooth decay of the crown
* Primary molars with discoloration
* Cracked tooth
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amany hasanean Abd El sadek
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amany hasanean Abd El sadek
student
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1692
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.